Comparative study of drug release in vitro of polylactic acid/polyglycolic acid coated triple anti-tuberculosis drug-loading artificial bone

wang qian,liu haitao,shi jiandang,wang zili,geng guangqi,niu ningkui,wang jie,yan junfa
DOI: https://doi.org/10.3969/j.issn.2095-4344.2017.06.016
2017-01-01
Abstract:BACKGROUND: Calcium sulfate/polyamino acid artificial bone material carrying triple anti-tuberculosis drugs(isoniazide, rifampicin, pyrazinamide) has good release characteristics and antibacterial activity, but its shortcomings also exist for the phenomenon of burst, due to a faster degradation of calcium sulfate.OBJECTIVE: To observe the effect of polylactic acid/polyglycolic acid copolymer(PLGA) coating on drug release behavior in vitro of triple anti-tuberculosis drugs containing calcium sulfate/polyamino acid bone. METHODS: According to the selected optimum recipe, we prepared drug-loading artificial bones and non-drug-loading artificial bones in a dark place. After infiltrating in PLGA, drying and sterilizing, we soaked them in simulated body fluid for drug release experiments. Through high performance liquid chromatography method, the concentrations of isoniazide, rifampicin, pyrazinamide released at different times were observed. RESULTS AND CONCLUSION: For triple anti-tuberculosis drugs drug artificial bone with no PLGA coating, the drug release of isoniazide accounted for 91.75% of the total drug loading capacity at 7 weeks; the drug releases of rifampicin and pyrazinamide respectively accounted for 88.34% and 49.35% of their own total drug loading capacity at 8 weeks. For triple anti-tuberculosis drug artificial bone with PLGA coating, the drug release of isoniazide accounted for 43.51% of the total drug loading capacity at 17 weeks; the drug releases of rifampicin and pyrazinamide respectively accounted for 15.92% and 48.42% of their own total drug loading capacity at 16 weeks. For blank control group, the drug peak was not noticed in effective detection period. These findings indicate that PLGA coated triple anti-tuberculosis drug-loading calcium sulfate/polyamino acid artificial bone can control drug release, increase the release period and maintain a high level of drug concentration in local lesion for a long time, so as to give full play to the anti-tuberculosis function of triple anti-tuberculosis drug loading artificial bone.
What problem does this paper attempt to address?